SD Biosensor, Inc. (KRX:137310)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,690.00
-90.00 (-1.03%)
At close: Feb 6, 2026

SD Biosensor Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
696,133694,574655,6772,932,0012,929,9611,686,163
Other Revenue
---0---
696,133694,574655,6772,932,0012,929,9611,686,163
Revenue Growth (YoY)
3.27%5.93%-77.64%0.07%73.77%2211.01%
Cost of Revenue
359,277357,603533,2271,541,8911,336,785829,530
Gross Profit
336,856336,971122,4491,390,1101,593,176856,633
Selling, General & Admin
217,936194,593206,811169,176177,655102,344
Research & Development
79,42187,94664,20345,76219,08610,388
Amortization of Goodwill & Intangibles
87,94886,50676,2574,443506.34168.5
Other Operating Expenses
5,8353,2292,8103,5271,571716.9
Operating Expenses
405,211391,442370,534243,486205,443118,369
Operating Income
-68,355-54,471-248,0851,146,6241,387,733738,264
Interest Expense
-69,184-68,589-49,228-994.06-488.66-433.63
Interest & Investment Income
23,76322,30423,48726,4866,702489.67
Currency Exchange Gain (Loss)
20,08030,876-22,71092,36265,296-26,100
Other Non Operating Income (Expenses)
-20,109-2,221-44,224-12,500-3,359-487.1
EBT Excluding Unusual Items
-113,576-72,101-340,7591,251,9791,455,883711,734
Gain (Loss) on Sale of Investments
-13,577-15,9103,059547.9512,2826,084
Gain (Loss) on Sale of Assets
8,4964,092-1,045-1,804-1,373-580.55
Asset Writedown
-135,262-135,262-99,869-8,634-2,283-
Pretax Income
-253,919-219,181-438,6141,242,0881,464,509717,237
Income Tax Expense
-366,167-121,04129,290333,300376,38595,623
Earnings From Continuing Operations
112,248-98,140-467,904908,7891,088,124621,614
Minority Interest in Earnings
967.14-271.22192.562,574346.26-5,978
Net Income
113,215-98,411-467,712911,3621,088,471615,636
Net Income to Common
113,215-98,411-467,712911,3621,088,471615,636
Net Income Growth
----16.27%76.80%19424.28%
Shares Outstanding (Basic)
1201221111019893
Shares Outstanding (Diluted)
1201221111019894
Shares Change (YoY)
-1.64%10.23%9.44%3.87%4.28%13.55%
EPS (Basic)
941.16-805.31-4218.958996.7611161.386597.15
EPS (Diluted)
941.16-805.31-4219.008996.7611161.006583.00
EPS Growth
----19.39%69.54%17223.68%
Free Cash Flow
236,81477,744-384,884587,0081,044,892440,478
Free Cash Flow Per Share
1968.63636.19-3471.825794.8110714.524710.19
Dividend Per Share
200.000200.000----
Gross Margin
48.39%48.52%18.68%47.41%54.37%50.80%
Operating Margin
-9.82%-7.84%-37.84%39.11%47.36%43.78%
Profit Margin
16.26%-14.17%-71.33%31.08%37.15%36.51%
Free Cash Flow Margin
34.02%11.19%-58.70%20.02%35.66%26.12%
EBITDA
70,48687,222-110,5431,187,4441,406,848746,239
EBITDA Margin
10.13%12.56%-16.86%40.50%48.02%44.26%
D&A For EBITDA
138,841141,694137,54140,82019,1157,974
EBIT
-68,355-54,471-248,0851,146,6241,387,733738,264
EBIT Margin
-9.82%-7.84%-37.84%39.11%47.36%43.78%
Effective Tax Rate
---26.83%25.70%13.33%
Advertising Expenses
-4,4765,98814,83010,3292,050
Source: S&P Global Market Intelligence. Standard template. Financial Sources.